Researcher charged in major HIV vaccine fraud case

by Ryan J. Foley

Responding to a major case of research misconduct, federal prosecutors are taking a rare step by charging a scientist with fraud after he admitted falsifying data while researching an HIV vaccine.

Authorities say former Iowa State University laboratory manager Dong-Pyou Han has confessed to manipulating data that helped his team get millions in grants and increased hopes of a major breakthrough in AIDS research.

Experts say the was particularly brazen, and charges are rarely brought in part because less money is usually involved. The National Institutes of Health is reviewing the case's impact on research it funds.

Han resigned from the university last fall. He was indicted last week and could face prison time if convicted. He's free on bond but didn't respond to a message seeking comment Tuesday.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Court sides with US in cell-tracking records case (Update)

May 09, 2014

The Justice Department does not have to turn over information on cases involving warrantless cellphone tracking if the cases ended without a defendant's conviction, a divided U.S. appeals court ruled Friday in upholding privacy ...

UK researcher sentenced to three months' jail for faking data

Apr 19, 2013

A British scientist convicted of scientific fraud last month for falsifying research data has been sentenced to three months jail. Steven Eaton is the first person to serve time under the UK's Good Laboratory Practice Regulations, 1999. ...

Recommended for you

Determine patient preferences by means of conjoint analysis

19 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments